Clinical Trial

A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension

Study acronym: TRÍADE-HA
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study if to evaluate the efficacy and safety of TCA108 on treatment of hypertension.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-18; most recent amendment 2026-07-08.
Trial Details
NCT Number NCT07030101
Lead Sponsor EMS
Conditions Hypertension
Enrollment 400 participants
Start Date 2026-11
Primary Completion 2029-05 (estimated)
Study Completion 2029-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-10